Matthew Reaney

Senior Principal Scientist, Patient Centered Endpoints, IQVIA


The Patient’s Voice is Finally Being Heard in Diabetes Drug Research

May 15, 2015

Type 2 diabetes mellitus is one of the Western world’s most common chronic conditions, with global prevalence increasing rapidly.

Patient Perspective Plays Important Role in Development of New Diabetes Treatment

March 30, 2015

Trulicity® (dulaglutide), approved by the EMA in November 2014 for the treatment of Type 2 diabetes in adults, is the first diabetes drug to have a Patient Reported Outcome.